Figure 3From: Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study Kaplan-Meier estimates of colorectal cancer-specific survival according to combinations of gender and positive versus negative cyclin D1 expression. Colorectal cancer-specific survival in (A) all patients, (B) patients with stage I-II disease and (C) patients with stage III-IV disease. Log-rank P values correspond to pairwise comparisons of cyclin D1-negative tumors in male patients with the other strata, respectively.Back to article page